Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt
Clinical trial NCT03454503 · COMPLETED
Trial details
- NCT number
- NCT03454503
- Sponsor
- Hikma Pharmaceuticals LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-05-13
- Primary completion
- 2020-12-28
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.